Seroatlas · Human Serome Atlas

APOO

MICOS complex subunit MIC26

Also known as: FAM121B, MGC4825, Mic23, MIC26, MIC26_HUMAN, MICOS26, My025

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q9BUR5
Gene
APOO
Ensembl
ENSG00000184831
Chromosome
X
Canonical length
198 aa
Protein class
Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters
Subcellular location
Mitochondria,Cytosol
Secretome location
Secreted to blood

OverviewNCBI Gene

This gene is a member of the apolipoprotein family. Members of this protein family are involved in the transport and metabolism of lipids. The encoded protein associates with HDL, LDL and VLDL lipoproteins and is characterized by chondroitin-sulfate glycosylation. This protein may be involved in preventing lipid accumulation in the myocardium in obese and diabetic patients. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 3, 4, 5, 12 and 16.[provided by RefSeq, Sep 2009]

Canonical amino-acid sequenceUniProt

198 residues, UniProt reviewed canonical sequence.

>Q9BUR5|APOO
     1  MFKVIQRSVG PASLSLLTFK VYAAPKKDSP PKNSVKVDEL SLYSVPEGQS KYVEEARSQL
    61  EESISQLRHY CEPYTTWCQE TYSQTKPKMQ SLVQWGLDSY DYLQNAPPGF FPRLGVIGFA
   121  GLIGLLLARG SKIKKLVYPP GFMGLAASLY YPQQAIVFAQ VSGERLYDWG LRGYIVIEDL
   181  WKENFQKPGN VKNSPGTK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against APOO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Secreted
Secreted
Yes
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.55
Highest tissue expression
103 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 103 nTPM
  • tongue: 68 nTPM
  • heart muscle: 62 nTPM
  • parathyroid gland: 58 nTPM
  • cerebral cortex: 56 nTPM
  • retina: 49 nTPM

Single-cell type

  • papillary tip epithelial cells: 273 nCPM
  • enteric stem cells: 169 nCPM
  • parietal cells: 159 nCPM
  • renal collecting duct principal cells: 153 nCPM
  • oocytes: 147 nCPM
  • enteric transient amplifying cells: 147 nCPM

Immune cell

  • MAIT T-cell: 17 nTPM
  • plasmacytoid DC: 17 nTPM
  • non-classical monocyte: 16 nTPM
  • intermediate monocyte: 16 nTPM
  • basophil: 15 nTPM
  • myeloid DC: 14 nTPM

Brain region

  • choroid plexus: 53 nTPM
  • medulla oblongata: 34 nTPM
  • hypothalamus: 33 nTPM
  • cerebellum: 32 nTPM
  • hippocampal formation: 31 nTPM
  • basal ganglia: 31 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about APOO.

Disease | GeneticClinVar

1 pathogenic / likely-pathogenic of 114 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.55
gnomAD pLI
0.6
gnomAD missense Z
-0.04
DepMap mean gene effect
0.06
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of APOO in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads APOO as an antibody target. Whether an autoantibody or antibody against APOO could matter depends on whether native APOO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

APOO is annotated as secreted, so native APOO circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.

Annotation status

The present source text does not explicitly label APOO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/APOO. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...